secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tyra Biosciences, Inc. (TYRA)
CIK:        0001863127
Form:       8-K
Filed at:   2026-06-02T20:01:13+00:00
Accession:  0001193125-26-253435
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tyra Biosciences elects three Class II directors, ratifies Ernst & Young as auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- Habib J. Dable, Susan Moran, and Robert More elected Class II directors for three-year terms.
- Robert More received 41,013,686 for and 3,705,719 withheld (8.3% withheld); Dable and Moran had under 1.1% withheld.
- Ernst & Young ratification: 53,092,820 for, 1,316 against, 3,246 abstentions; no broker non-votes on this proposal.
- Broker non-votes on director election: 8,377,977 for each director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/0001193125-26-253435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/d33725d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-253435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer